You are receiving this message since your browser does not support Java Script or you have Java Scripts disabled. The following disclaimer is provided as an alternative to the information that would normally be seen on your monitor when you click on a link to a non-federal site.

"You are now leaving the NIDDK website. The NIDDK is not responsible for the content of web pages found on this linked website. Links to nonfederal organizations are provided solely as a service to our users. These links do not indicate an endorsement of these organizations by NIDDK or the federal government."

Type 1 Diabetes (T1D) Special Statutory Funding Program

Research Consortia and Clinical Trials Networks

Pre-Clinical Development of Therapeutic Agents

Type 1 Diabetes-Preclinical Testing Program (T1D-PTP)
The Type 1 Diabetes-Preclinical Testing Program was developed to provide investigators with access to the established facilities and expertise needed to extend, enhance, and validate preclinical studies of promising new therapeutics. More Information

Type 1 Diabetes-Rapid Access to Intervention Development (T1D-RAID)
The T1D-RAID program provides resources for pre-clinical development of drugs, natural products, and biologics that will be tested in type 1 diabetes clinical trials. More Information

Return to Research Consortia and Clinical Trials Networks Topic List



Last Updated: June 30, 2008

General Inquiries may be addressed to:
Office of Communications and Public Liaison
NIDDK, NIH
Building 31, Rm 9A06
31 Center Drive, MSC 2560
Bethesda, MD 20892-2560 USA
For information about NIDDK programs: 301.496.3583